PRINTABLE VERSIONPRINTABLE VERSION EMAILEMAIL
Frost & Sullivan Recognizes Iris BioTechnologies for Technology Innovation in the Pharmacogenomics Arena
Date Published: 8 Jul 2008

The Nano-BioChip™ and informatics system together is designed to assist physicians in quickly prescribing the most effective, customized treatment protocol for patients based on their genetic imprints and other aspects central to a disease's incidence, such as lifestyle and environmental factors. For patients, this technology would be pivotal in yielding a personalized treatment regimen, with the greatest possibility of success.

Read the full article here.

BACK TO TOP BACK TO TOP

QUICK SEARCH

GO GO
ADVANCED SEARCH
Search our research by date, market, technology, region or keywords
GO GO
CHAIRMAN'S SERIES ON GROWTH
GROWTH OPPORTUNITY NEWSLETTERS
THOUGHT LEADER FORUM
Discover how we can help your business
GO  GO
Learn how we can provide data and insight for your specific requirements
GO  GO
HELP DESK
For general assistance and enquiries:
Asia Pacific:
+65 68900999
apacfrost@frost.com

Europe & Africa:
+44 (0)20 7343 8383
enquiries@frost.com

Latin America:
+54 11 4777 1550
myfrost.la@frost.com

Middle East & North Africa:
+971.4.4331.893
meenquiries@frost.com

North America:
+1.877.463.7678
myfrost@frost.com

South Asia:
+91 (0) 22-40013400
saenquiries@frost.com

For a full list of our offices click here
Sitemap | Disclaimer | Privacy
© Frost & Sullivan
Conseq